drug · small molecule
patient view →tolcapone
Phase 2updated 2mo agoby Corino Therapeutics Inc🔗 ChEMBL
Phase 2community read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with an approval for parkinson disease and hepatic failure and 14 investigational indications.
indications
indications
Parkinson's Disease
targets
Catechol O-methyltransferase
all catalysts(0)
nothing on the calendar yet
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that